201 related articles for article (PubMed ID: 3513530)
1. Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension.
Wilson MF; Haring O; Lewin A; Bedsole G; Stepansky W; Fillingim J; Hall D; Roginsky M; McMahon FG; Jagger P
Am J Cardiol; 1986 Mar; 57(9):43E-49E. PubMed ID: 3513530
[TBL] [Abstract][Full Text] [Related]
2. Clonidine and guanfacine in hypertension.
Jain AK; Hiremath A; Michael R; Ryan JR; McMahon FG
Clin Pharmacol Ther; 1985 Mar; 37(3):271-6. PubMed ID: 3882307
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized, double-blind dose-response evaluation of step-2 guanfacine versus placebo in mild to moderate hypertension.
Materson BJ; Kessler WB; Alderman MH; Canosa FL; Finnerty FA; Savran SV; McMillen JI; Marlon AM
Am J Cardiol; 1986 Mar; 57(9):32E-37E. PubMed ID: 3513528
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of low dose guanfacine, once a day, for 24-hour control of essential hypertension.
Keenan RE; Black PL; Freudenburg JC; Hill JA; Holmburg CE; Reitbrock MJ; Sullivan MJ; Thompson MT; Wright DL
Am J Cardiol; 1986 Mar; 57(9):38E-42E. PubMed ID: 3513529
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of guanfacine and clonidine in essential hypertension: a single-blind crossover study.
Miach PJ; Louis WJ
Med J Aust; 1980 Oct; 2(7):395-6. PubMed ID: 7005630
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive effect of guanfacine: a double-blind cross-over trial compared with clonidine.
Distler A; Kirch W; Lüth B
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):49S-53S. PubMed ID: 6994778
[TBL] [Abstract][Full Text] [Related]
7. [A new antihypertensive agent used in a clinical setting].
Wetzels E; Raschig A; Kaiser HJ
Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
[TBL] [Abstract][Full Text] [Related]
8. Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.
Sorkin EM; Heel RC
Drugs; 1986 Apr; 31(4):301-36. PubMed ID: 3519177
[TBL] [Abstract][Full Text] [Related]
9. Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine.
Lauro R; Reda G; Spallone L; Anguissola AB
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):81S-82S. PubMed ID: 6994784
[No Abstract] [Full Text] [Related]
10. Comparison of guanfacine and clonidine as antihypertensive agents.
Jäättelä A
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6994782
[TBL] [Abstract][Full Text] [Related]
11. Guanfacine as monotherapy for systemic hypertension.
Fillingim JM; Blackshear JL; Strauss A; Strauss M
Am J Cardiol; 1986 Mar; 57(9):50E-54E. PubMed ID: 3513531
[TBL] [Abstract][Full Text] [Related]
12. Precipitation by yohimbine of the withdrawal syndromes of clonidine, guanfacine, and methyldopa in the spontaneously hypertensive rat.
Thoolen MJ; Hendriks JC; Timmermans PB; van Zwieten PA
J Cardiovasc Pharmacol; 1983; 5(2):224-8. PubMed ID: 6188894
[TBL] [Abstract][Full Text] [Related]
13. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
14. Effects of abrupt cessation of treatment with clonidine and guanfacine on blood pressure and heart rate in spontaneously hypertensive rats.
Koike Y; Togashi H; Shimamura K; Yomaida I; Saito H
Clin Exp Hypertens (1978); 1981; 3(1):103-20. PubMed ID: 7009101
[TBL] [Abstract][Full Text] [Related]
15. Long-term antihypertensive therapy with guanfacine.
Szám I; Holló J
Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702
[TBL] [Abstract][Full Text] [Related]
16. Effects of clonidine and guanfacine in essential hypertension.
Farsang C; Varga K; Vajda L; Alföldi S; Kapocsi J
Clin Pharmacol Ther; 1984 Nov; 36(5):588-94. PubMed ID: 6386275
[TBL] [Abstract][Full Text] [Related]
17. [Comparative effectiveness of alpha-2 adrenergic agonists (clonidine-guanfacine) in the hospital detoxification of opiate addicts].
Muga R; Tor J; Forteza-Rei J; Jacas C; Altés J; Mestre L
Med Clin (Barc); 1990 Feb; 94(5):169-72. PubMed ID: 1969980
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.
Jerie P
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):157S-164S. PubMed ID: 6994770
[No Abstract] [Full Text] [Related]
19. Antihypertensive effect of guanfacine: long-term 'once-a-day' treatment and sudden withdrawal.
Szám I; Holló J
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():469s-471s. PubMed ID: 7032828
[TBL] [Abstract][Full Text] [Related]
20. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
Rhomberg F; Widler J
Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
